Max J. Kellner

11.6k citations
22 papers · 9.3k · 6 hit papers · h-index 16

Impact in

    • CRISPR and Genetic Engineering
    • Advanced biosensing and bioanalysis techniques
    • RNA regulation and disease
    • RNA Research and Splicing
    • RNA Interference and Gene Delivery
    • SARS-CoV-2 detection and testing
    • SARS-CoV-2 and COVID-19 Research

Papers in

    • SARS-CoV-2 and COVID-19 Research 4
    • SARS-CoV-2 detection and testing 3
    • CRISPR and Genetic Engineering 8
    • RNA regulation and disease 3
    • Ubiquitin and proteasome pathways 1

Max J. Kellner

22 papers receiving 9k citations

Max J. Kellner's Hit Papers

Angiotensin-converting enzyme 2—at the heart of the COVID-19 pandemic 2023 · 88 citations
880+3+6Years since publication5001k1.5k2k

Peers

Max J. Kellner
Comparison fields: 5 of 134
  • Molecular Biology 6k
  • Infectious Diseases 1.4k
  • Biomedical Engineering 2.4k
  • Cancer Research 205
  • Neurology 201
Replace Lee Gehrke with:
Lee Gehrke United States
Thomas J. Hope United States
Vanessa K. Verdine United States
Stephen Albert Johnston United States
Stefan Dübel Germany
Ian M. Slaymaker United States
Irene Bosch United States
Winston X. Yan United States
Craig B. Wilen United States
Sergei V. Strelkov Belgium
Max J. Kellner relative to Lee Gehrke United States Lee Gehrke's profile →
Citations per field
00.5×2×2.7×
Lee Gehrke · 1×
Citations per year

Countries citing papers authored by Max J. Kellner

Since Specialization
Citations

This map shows the geographic impact of Max J. Kellner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max J. Kellner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max J. Kellner more than expected).

Fields of papers citing papers by Max J. Kellner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Max J. Kellner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max J. Kellner. The network helps show where Max J. Kellner may publish in the future.

Co-authors

The 25 scholars most cited alongside Max J. Kellner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Max J. Kellner Line = papers co-authored together Max J. Kellner links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6
Hit paper breakdown →
20182184
2
RNA targeting with CRISPR–Cas13
Hit paper breakdown →
20171686
3
RNA editing with CRISPR-Cas13
Hit paper breakdown →
20171494
4
SHERLOCK: nucleic acid detection with CRISPR nucleases
Hit paper breakdown →
20191299
5
Field-deployable viral diagnostics using CRISPR-Cas13
Hit paper breakdown →
20181193
6 2020434
7 2019382
8 2019104
9 2019104
10
Angiotensin-converting enzyme 2—at the heart of the COVID-19 pandemic
Hit paper breakdown →
202388
11 202159
12 202153
13 201949
14 202244
15 202230
16 202429
17 202115
18 202310
19 202510
20 20259

About Max J. Kellner

Max J. Kellner is a scholar working on Infectious Diseases, Molecular Biology, Biomedical Engineering, Immunology and Neurology, having authored 22 papers that have together received 9.3k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (8 papers), Biosensors and Analytical Detection (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers), SARS-CoV-2 detection and testing (3 papers), RNA regulation and disease (3 papers), interferon and immune responses (2 papers), Plant Molecular Biology Research (1 paper) and Ubiquitin and proteasome pathways (1 paper). The work is most often cited by research in Molecular Biology (6k citations), Infectious Diseases (1.4k citations), Biomedical Engineering (2.4k citations), Cancer Research (205 citations) and Neurology (201 citations). Max J. Kellner has collaborated with scholars based in Austria, United States and Sweden. Frequent co-authors include Jonathan S. Gootenberg, Omar O. Abudayyeh, Feng Zhang, Julia Joung, James J. Collins, Jeremy G. Koob, Joseph J. Belanto, Daniel F. Voytas, Vanessa K. Verdine and Aviv Regev. Their work appears in journals such as Science, Nature Communications, Cell Reports, Cell and Life Science Alliance.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact